aszonalenin: structure in first source
ID Source | ID |
---|---|
PubMed CID | 42636439 |
CHEBI ID | 192681 |
MeSH ID | M000611177 |
Synonym |
---|
81797-27-5 |
aszonalenin |
nsc-374337 |
CHEBI:192681 |
(2r,3s,11r)-aszonalenin |
(2r,3s,11r)-aszonalenin zwitterion |
aszonalenine |
aszonalenine, (+)- |
(5ar,13ar,14as)-14a-(1,1-dimethyl-2-propenyl)-5a,13a,14,14a-tetrahydroindolo(3',2':4,5)pyrrolo(2,1-c)(1,4)benzodiazepine-7,13(5h,12h)-dione |
indolo(3',2':4,5)pyrrolo(2,1-c)(1,4)benzodiazepine-7,13(5h,12h)-dione, 14a-(1,1-dimethyl-2-propenyl)-5a,13a,14,14a-tetrahydro-, (5ar,13ar,14as)- |
0v5dq674au , |
indolo(3',2':4,5)pyrrolo(2,1-c)(1,4)benzodiazepine-7,13(5h,12h)-dione, 14a-(1,1-dimethyl-2-propenyl)-5a,13a,14,14a-tetrahydro-, (5ar-(5aalpha,13abeta,14aalpha))- |
unii-0v5dq674au |
indolo(3',2':4,5)pyrrolo(2,1-c)(1,4)benzodiazepine-7,13(5h,12h)-dione, 14a-(1,1-dimethyl-2-propenyl)-5a,13a,14,14a-tetrahydro-, (5ar-(5a.alpha.,13a.beta.,14a.alpha.))- |
[5ar,(+)]-14abeta-(1,1-dimethyl-2-propenyl)-5abeta,13aalpha,14,14a-tetrahydroindolo[3',2' |
HY-123006 |
CS-0079843 |
Epi-aszonalenin A (EAA) is an alkaloid that is isolated and purified from the secondary metabolites of coral symbiotic fungi. EAA has been shown to have good atherosclerotic intervention activity and anti-angiogenic activity.
Excerpt | Reference | Relevance |
---|---|---|
"Epi-aszonalenin A (EAA) is an alkaloid that is isolated and purified from the secondary metabolites of coral symbiotic fungi and has been shown to have good atherosclerotic intervention activity and anti-angiogenic activity in our previous studies. " | ( Mechanisms of Antitumor Invasion and Metastasis of the Marine Fungal Derivative Epi-Aszonalenin A in HT1080 Cells. He, YL; Hong, P; Li, Y; Lin, L; Liu, Y; Qian, ZJ; Sun, S; Zhang, Y; Zheng, H; Zhou, C, 2023) | 1.69 |
Class | Description |
---|---|
benzodiazepine | A group of heterocyclic compounds with a core structure containing a benzene ring fused to a diazepine ring. |
zwitterion | A neutral compound having formal unit electrical charges of opposite sign on non-adjacent atoms. Sometimes referred to as inner salts, dipolar ions (a misnomer). |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.92) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |